Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors.

Jonas O, Landry HM, Fuller JE, Santini JT Jr, Baselga J, Tepper RI, Cima MJ, Langer R.

Sci Transl Med. 2015 Apr 22;7(284):284ra57. doi: 10.1126/scitranslmed.3010564.

2.

A thin commentary on a fat receptor.

Tartaglia LA, Tepper RI.

Cell. 2004 Jan 23;116(2 Suppl):S121-2, 1 p following S122. No abstract available.

3.

Glycoprotein IIb/IIIa inhibitor therapy and outcomes after percutaneous coronary intervention.

Tepper RI, Simonian N.

Am J Cardiol. 2003 Sep 15;92(6):771-2. No abstract available.

PMID:
12972136
4.

Inhibition of angiogenesis by interleukin 4.

Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP.

J Exp Med. 1998 Sep 21;188(6):1039-46.

5.

Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.

Duncan LM, Deeds J, Hunter J, Shao J, Holmgren LM, Woolf EA, Tepper RI, Shyjan AW.

Cancer Res. 1998 Apr 1;58(7):1515-20.

6.

Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway.

Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I.

Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3302-7.

7.

T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection.

Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA.

J Immunol. 1997 Jan 1;158(1):315-21.

PMID:
8977205
8.

Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.

Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP.

Cell. 1996 Feb 9;84(3):491-5.

9.

Identification and expression cloning of a leptin receptor, OB-R.

Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI.

Cell. 1995 Dec 29;83(7):1263-71.

10.

Gene therapy of metastatic cancer by in vivo retroviral gene targeting.

Hurford RK Jr, Dranoff G, Mulligan RC, Tepper RI.

Nat Genet. 1995 Aug;10(4):430-5.

PMID:
7670493
11.

Analysis of mast cell activation using diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry.

Dvorak AM, Morgan ES, Monahan-Earley RA, Estrella P, Schleimer RP, Weller PF, Tepper RI, Lichtenstein LM, Galli SJ.

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):87-9. Review.

PMID:
7542108
12.

Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer.

Wei MX, Tamiya T, Hurford RK Jr, Boviatsis EJ, Tepper RI, Chiocca EA.

Hum Gene Ther. 1995 Apr;6(4):437-43.

PMID:
7612701
13.

IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo.

Wang L, Goillot E, Tepper RI.

Cell Immunol. 1994 Dec;159(2):152-69.

PMID:
7994751
14.

The eosinophil-mediated antitumor activity of interleukin-4.

Tepper RI.

J Allergy Clin Immunol. 1994 Dec;94(6 Pt 2):1225-31. Review. No abstract available.

PMID:
7798564
16.

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.

Boviatsis EJ, Chase M, Wei MX, Tamiya T, Hurford RK Jr, Kowall NW, Tepper RI, Breakefield XO, Chiocca EA.

Hum Gene Ther. 1994 Feb;5(2):183-91.

PMID:
8186298
17.

Experimental and clinical studies of cytokine gene-modified tumor cells.

Tepper RI, Mulé JJ.

Hum Gene Ther. 1994 Feb;5(2):153-64. Review.

PMID:
8186297
18.

The anti-tumour and proinflammatory actions of IL4.

Tepper RI.

Res Immunol. 1993 Oct;144(8):633-7. Review. No abstract available.

PMID:
8303081
19.

Treatment of glioma by engineered interleukin 4-secreting cells.

Yu JS, Wei MX, Chiocca EA, Martuza RL, Tepper RI.

Cancer Res. 1993 Jul 1;53(13):3125-8.

20.

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice.

Rich BE, Campos-Torres J, Tepper RI, Moreadith RW, Leder P.

J Exp Med. 1993 Feb 1;177(2):305-16.

21.

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.

Tepper RI, Coffman RL, Leder P.

Science. 1992 Jul 24;257(5069):548-51.

PMID:
1636093
22.

The tumor-cytokine transplantation assay and the antitumor activity of interleukin-4.

Tepper RI.

Bone Marrow Transplant. 1992;9 Suppl 1:177-81. Review. No abstract available.

PMID:
1504664
23.

Humoral immune functions in IL-4 transgenic mice.

Burstein HJ, Tepper RI, Leder P, Abbas AK.

J Immunol. 1991 Nov 1;147(9):2950-6.

PMID:
1919000
24.

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P.

Cell. 1990 Aug 10;62(3):457-67.

PMID:
2116236
25.

Murine interleukin-4 displays potent anti-tumor activity in vivo.

Tepper RI, Pattengale PK, Leder P.

Cell. 1989 May 5;57(3):503-12.

PMID:
2785856

Supplemental Content

Loading ...
Support Center